Lanean...
Gemcitabine for Advanced Endometrial Cancer: A Review of the MSKCC Experience
BACKGROUND: Gemcitabine has been used in an off-label setting for treatment of advanced endometrial cancer (EMC), but there is a lack of published data showing its efficacy in treating this disease. We performed a retrospective review to determine the progression-free survival (PFS) and response rat...
Gorde:
| Egile Nagusiak: | , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2012
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3904291/ https://ncbi.nlm.nih.gov/pubmed/22635030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IGC.0b013e31824a33a2 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|